Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial-Reference-Cited by-同舟云学术

Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial

Published:2014-03 Issue:3 Volume:2 Page:187-194
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Zheng Jin-Ping,Wen Fu-Qiang,Bai Chun-Xue,Wan Huan-Ying,Kang Jian,Chen Ping,Yao Wan-Zhen,Ma Li-Jun,Li Xia,Raiteri Luca,Sardina Marco,Gao Yi,Wang Bai-Song,Zhong Nan-Shan

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference33 articles.

1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary;Vestbo;Am J Respir Crit Care Med,2013

2. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease;Donaldson;Thorax,2002

3. Impact of preventing exacerbations on deterioration of health status in COPD;Spencer;Eur Respir J,2004

4. The burden of COPD in The Netherlands: results from the confronting COPD survey;Wouters;Respir Med,2003

5. In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation;Blackwell;J Immunol,1996

Cited by 203 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N-acetyl-cysteine in Intensive Care Unit Patients with Acute Respiratory Distress Syndrome due to COVID-19: A Retrospective Cohort Study;Journal of Intensive Care Medicine;2024-09-11

2. The effect of nebulized N-acetylcysteine on the phlegm of chronic obstructive pulmonary disease: the NEWEST study;BMC Pulmonary Medicine;2024-09-02

3. Adjunctive N-Acetylcysteine and Lung Function in Pulmonary Tuberculosis;NEJM Evidence;2024-08-27

4. Effective-Component Compatibility of Bufei Yishen Formula III Suppresses Mitochondrial Oxidative Damage in COPD: Via Pkm2/Nrf2 Pathway;International Journal of Chronic Obstructive Pulmonary Disease;2024-08

5. Anti-Inflammatory and Anti-Oxidant Properties of N-Acetylcysteine: A Fresh Perspective;Journal of Clinical Medicine;2024-07-15